CATALOGO DEI PRODOTTI DELLA RICERCA

GAIBANI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.893
AS - Asia 2.666
EU - Europa 2.214
SA - Sud America 477
Continente sconosciuto - Info sul continente non disponibili 216
AF - Africa 170
OC - Oceania 4
Totale 8.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.798
RU - Federazione Russa 1.384
SG - Singapore 1.212
IT - Italia 467
HK - Hong Kong 393
BR - Brasile 370
VN - Vietnam 262
BD - Bangladesh 253
CN - Cina 253
GB - Regno Unito 142
KR - Corea 121
BJ - Benin 59
DE - Germania 49
IN - India 42
NG - Nigeria 42
AR - Argentina 38
CA - Canada 36
MX - Messico 35
NL - Olanda 29
EC - Ecuador 23
FI - Finlandia 23
AT - Austria 18
ZA - Sudafrica 17
FR - Francia 16
ID - Indonesia 16
IQ - Iraq 16
TR - Turchia 16
PL - Polonia 15
VE - Venezuela 15
ES - Italia 14
PY - Paraguay 12
TG - Togo 12
IE - Irlanda 11
SE - Svezia 10
UA - Ucraina 10
JP - Giappone 9
PK - Pakistan 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
KE - Kenya 8
PH - Filippine 8
CL - Cile 7
MA - Marocco 7
DZ - Algeria 6
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
TN - Tunisia 4
AU - Australia 3
BY - Bielorussia 3
CO - Colombia 3
GT - Guatemala 3
HN - Honduras 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BW - Botswana 2
EG - Egitto 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
LT - Lituania 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
ZW - Zimbabwe 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CU - Cuba 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LR - Liberia 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 8.414
Salva come PNG Salva come JPEG
Città #
Singapore 688
San Jose 672
Ashburn 606
Dallas 532
Moscow 453
Hong Kong 392
Verona 171
The Dalles 140
Council Bluffs 111
Ho Chi Minh City 85
London 73
Hanoi 72
Los Angeles 72
New York 61
Buffalo 59
Cotonou 59
Redondo Beach 54
Abuja 39
Santa Clara 38
São Paulo 38
Beijing 35
Milan 35
Rome 34
Mexico City 23
Munich 19
Montreal 18
Chandler 16
Bologna 15
Da Nang 15
Warsaw 15
Nuremberg 14
Brooklyn 13
Lomé 12
Naples 12
Porto Alegre 12
Helsinki 11
Woodbridge 11
Dublin 10
Amsterdam 9
Atlanta 9
Biên Hòa 9
Chennai 9
Chicago 9
Haiphong 9
Houston 9
Vienna 9
Belo Horizonte 8
New Delhi 8
Orem 8
Phoenix 8
Tashkent 8
Tokyo 8
Turin 8
Turku 8
Boston 7
Campinas 7
Guarulhos 7
Salvador 7
Toronto 7
Hải Dương 6
Jakarta 6
Nairobi 6
Quito 6
Rio de Janeiro 6
Southend 6
Stockholm 6
Baghdad 5
Betim 5
Bắc Ninh 5
Can Tho 5
Caracas 5
Casablanca 5
Columbus 5
Dhaka 5
Guayaquil 5
Johannesburg 5
Mumbai 5
Riyadh 5
San Francisco 5
Taranto 5
Valencia 5
Ambato 4
Asunción 4
Cape Town 4
Catania 4
Cesena 4
Curitiba 4
Erbil 4
Fortaleza 4
Frankfurt am Main 4
Genoa 4
Guangzhou 4
Jacksonville 4
Lahore 4
Madrid 4
Manassas 4
Maracaibo 4
North Bergen 4
Padua 4
Paris 4
Totale 5.099
Salva come PNG Salva come JPEG
Nome #
Epidemiology and Genomic Characterization of Trichophyton mentagrophytes over a Period of 4 Years in Northern Italy 309
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 157
Blood culture systems: rapid detection-how and why? 137
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients 124
Characterization of the genome of a Klebsiella pneumoniae clinical strain carrying a novel KPC-205 variant associated with resistance to ceftazidime/avibactam and cefiderocol 122
Clinical Characteristics and Genomic Analysis of a Trichophyton indotineae Strain Resistant to Terbinafine and Fluconazole Isolated in Italy 118
Performance evaluation of Bruker UMIC® microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species 111
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 107
Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying Novel Variant blaKPC-203, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023 100
Colistin: Lights and Shadows of an Older Antibiotic 94
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 93
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria 91
A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol 90
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 90
Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021 87
Case report of Usutu virus infection in an immunocompromised patient in Italy, 2022 85
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia 85
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections 83
Infections in liver and lung transplant recipients: a national prospective cohort 83
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 82
Rectal screening of carbapenemase-producing Enterobacteriaceae: a proposed workflow 82
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 82
Heterogeneity of West Nile virus genotype 1a in Italy, 2011 82
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients 82
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 81
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 81
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations 80
Comparative Usutu and West Nile virus transmission potential by local Culex pipiens mosquitoes in north-western Europe 78
A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid 77
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF) 77
Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia 76
Isolation and genome characterization of a Klebsiella pneumoniae clinical strain carrying blaNDM-5 and blaOXA-48 isolated in Italy 75
Genomic characterization of a high pathogenic Escherichia coli causing bacterial meningitis in a newborn in Italy, 2022: E. coli neonatal meningitis 75
Chikungunya: an emerging and spreading arthropod-borne viral disease 75
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations 75
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 74
A novel IncA plasmid carrying blaVIM-1 in a Kluyvera cryocrescens strain 74
In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates 73
Clinical application of a molecular method based on real time RT-PCR for detection od influenza A(H1N1)v 72
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study (2022-23) 72
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 72
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 71
Microbiological Investigation and Clinical Efficacy of Professional Topical Fluoride Application on Streptococcus mutans and Selemonas sputigena in Orthodontic Patients: A Randomized Controlled Clinical Trial 70
Mosquito, bird and human surveillance of west nile and usutu viruses in Emilia-Romagna region (Italy) in 2010 68
Resistance to sulbactam/durlobactam in carbapenem-resistant Acinetobacter baumannii in treatment-naive setting: in vitro data and genomic insights from Italian bloodstream isolates 68
Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health 66
Genomic epidemiology of Klebsiella pneumoniae: the Italian scenario, and novel insights into the origin and global evolution of resistance to carbapenem antibiotics 66
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia 65
Serodiagnosis of visceral leishmaniasis in northeastern italy: Evaluation of seven serological tests 65
Humans parasitized by the hard tick Ixodes ricinus are seropositive to Midichloria mitochondrii: is Midichloria a novel pathogen, or just a marker of tick bite? 64
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 64
Complete Genome Sequence of a Multidrug-Resistant Klebsiella pneumoniae Strain Carrying blaOXA181and blaKPC-125Carbapenemase 63
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments 63
In vivo emergence of ceftazidime/avibactam, cefiderocol and aztreonam/avibactam cross-resistance in a patient with KPC-producing Klebsiella pneumoniae infection after Cefiderocol-based treatment 62
Diagnostic methods for CHIKV based on serological tools 62
Toscana virus infections in northern Italy: laboratory and clinical evaluation 60
Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity 60
In vivo development of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series 59
The lower respiratory tract microbiome of critically ill patients with COVID-19 58
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies 58
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 57
Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC-Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020 57
Draft Genome of Klebsiella pneumoniae Sequence Type 512, a Multidrug-Resistant Strain Isolated during a Recent KPC Outbreak in Italy 56
Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy 56
Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae 55
Treponema Denticola alters cell vitality and induces HO1 and HSP70 expression in porcine Aortic Endothelial cells 55
In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam 54
Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010 54
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies 54
Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient 54
Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy 54
Complete genome sequence and antimicrobial resistance analysis of ESBL-producing Shigella sonnei carrying small cryptic plasmids isolated in northern Italy 54
In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producers 54
Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel 53
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 53
Evaluation of five carbapenemase detection assays for Enterobacteriaceae harbouring bla KPC variants associated with ceftazidime/avibactam resistance 52
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing 52
Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase 52
Phenotypic and genotypic characterization of Klebsiella pneumoniae strains with reduced susceptibiliy to carbapenems 52
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August- September 2009 51
Persistence of anti-west nile virus-specific antibodies among asymptomatic blood donors in Northeastern Italy 51
Do mosquito-associated bacteria of the genus Asaia circulate in humans? 51
Human infection with highly pathogenic a(H7N7) avian influenza virus, Italy, 2013 50
In vitro interaction of ceftazidimeâ avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 50
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring 49
The central region of the msp gene of Treponema denticola has sequence heterogeneity among clinical samples, obtained from patients with periodontitis 49
Serological and molecular tools to diagnose visceral leishmaniasis: 2-years' experience of a single center in Northern Italy 49
Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital 48
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 48
Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012 48
Evaluation of Phenotypic and Genotypic Approaches for the Detection of Class A and Class B Carbapenemases inEnterobacteriaceae 47
New evidence of cutaneous leishmaniasis in north-eastern Italy 47
The Gut Microbiota of Critically Ill Patients With COVID-19 47
Detection of West Nile virus RNA (lineages 1 and 2) in an external quality assessment programme for laboratories screening blood and blood components for West Nile virus by nucleic acid amplification testing 46
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment 46
Imported cases of dengue virus infection: Emilia-Romagna, Italy, 2010 46
Complete genome sequence of invasive Streptococcus pneumoniae serotype 11A causing meningitis in an adult patient, Italy 2022 46
Seroprevalence of West Nile virus antibodies in blood donors living in the metropolitan area of Milan, Italy, 2009-2011 46
Severe Escherichia coli infections in critical adult patients: two case reports and genomic analysis 46
Comparative genomic and phylogenetic analysis of the first usutu virus isolate from a human patient presenting with neurological symptoms 46
Totale 7.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.219
article - articoli 31.974
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 245
Totale 64.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 1 0 0 0 0 0 0 0 0 1 2
2022/202338 5 4 3 8 3 8 0 3 2 1 1 0
2023/202417 1 0 3 4 2 4 1 1 0 0 1 0
2024/20251.593 57 23 18 66 27 164 76 60 221 104 230 547
2025/20266.719 457 572 434 846 1.359 316 838 459 464 323 339 312
2026/2027227 179 48 0 0 0 0 0 0 0 0 0 0
Totale 8.640